Business Optimi enters psilocybin supply agreement to open healthcare centre in Costa Rica The psilocybin producer will be working with the Knowde Group, Inc., BC Green Pharmaceuticals Inc. and Promises Innovative Recovery (PIR) Natalia Buendia CalvilloAugust 30, 2022
Business Numinus reports sequential revenue dip of 5.7% The drop was due to a shift in Numinus Bioscience operations Natalia Buendia CalvilloJuly 15, 2022
Psychedelics MAPS has immense fundraising success Christie's helps psychedelic research group generate unprecedented revenue via crypto-asset art auction Rowan DunneJuly 4, 2022
Business Numinus completes Novamind acquisition, upgrades leadership team Novamind's clinics in Utah and Arizona will continue to operate as their current brand until later this year Natalia Buendia CalvilloJune 14, 2022
Business Optimi Health enters psilocybin mushroom supply agreement with Halucenex Life Sciences The shrooms will be supplied to Halucenex in the form of whole, dried mushroom fruiting bodies Natalia Buendia CalvilloMay 27, 2022
Business Field Trip to split into two independent companies Current shareholders of the firm will receive shares of each company Natalia Buendia CalvilloMay 3, 2022
Culture Numinus announces Music as Medicine event series Series of concerts across the U.S. and Canada will explore music’s role in psychedelic-assisted therapy Ryan GarnerMay 3, 2022
Business Recent acquisitions help Numinus bolster revenue 240 per cent year-over-year Numinus' gross margin improved to 29.1 per cent during Q2 2022 following acquisitions of Mindspace Psychology Services Inc. and the Neurology Centre of Toronto Ryan GarnerApril 19, 2022
Medical and Pharmaceutical Delic Labs granted permission to study psychedelics including LSD, MDMA The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds Ryan GarnerApril 15, 2022
Business Numinus to enter US psychedelics market via $26.2M Novamind acquisition The transaction is expected to close around June Natalia Buendia CalvilloApril 12, 2022